Published in J Clin Pathol on October 01, 1987
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest (1993) 1.51
Gastrointestinal complications of dialysis related amyloidosis. BMJ (1988) 0.91
Systemic amyloidosis of beta 2 microglobulin type. J Clin Pathol (1992) 0.90
Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement. J Clin Pathol (1997) 0.80
Cystic beta2-microglobulin amyloidoma in a patient on long-term hemodialysis. Clin Exp Nephrol (2006) 0.79
Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis. J Clin Pathol (1993) 0.78
Association of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patients. Medicine (Baltimore) (2016) 0.78
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med (1980) 9.38
A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun (1985) 3.40
Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol (1977) 1.83
Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest (1985) 1.54
Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med (1986) 1.10
Carpal tunnel syndrome: a major complication in long-term hemodialysis patients. Clin Nephrol (1984) 1.10
Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Arch Pathol Lab Med (1985) 1.08
Dialysis arthropathy: amyloid or iron? Br Med J (Clin Res Ed) (1986) 1.07
Beta 2-microglobulin-associated amyloidosis in chronic haemodialysis patients. Lancet (1986) 1.04
Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Hum Pathol (1986) 1.01
Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. Contrib Nephrol (1983) 0.92
Haemodialysis versus CAPD: equal predisposition to amyloidosis? Lancet (1986) 0.89
Hepatic copper distribution in primary biliary cirrhosis shown by the scanning proton microprobe. J Clin Pathol (1985) 0.82
Accumulation of silicone elastomer in regular dialysis. Proc Eur Dial Transplant Assoc (1983) 0.82
Acquired cystic disease of the kidney: serious or irrelevant? Br Med J (Clin Res Ed) (1986) 0.81
Protective effect of breast feeding against infection. BMJ (1990) 5.88
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Disease mapping models: an empirical evaluation. Disease Mapping Collaborative Group. Stat Med (2001) 2.88
Change in obstetric practice in response to fear of litigation in the British Isles. Lancet (1991) 2.78
Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65
Relation between early introduction of solid food to infants and their weight and illnesses during the first two years of life. BMJ (1993) 2.46
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet (1985) 2.40
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
Quality of life measurements in patients with malignant disease: a review. J R Soc Med (1986) 2.28
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int (1993) 2.07
The use of various handwashing agents to decontaminate gloved hands. Br Dent J (1989) 2.03
The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy (2007) 1.91
The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia (2009) 1.87
The evidence for beta blockers in heart failure. BMJ (1999) 1.84
The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology (1988) 1.83
Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy (2011) 1.81
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. Lancet (1974) 1.80
The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer (1984) 1.77
Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol (2001) 1.74
The heart failure epidemic: exactly how big is it? Eur Heart J (2001) 1.73
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73
Analysis of pace-maker and repolarization currents in frog atrial muscle. J Physiol (1976) 1.72
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J (1984) 1.72
A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int (1996) 1.70
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Br Med J (1966) 1.67
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta (2001) 1.63
Multivesicular exocytosis in rat pancreatic beta cells. Diabetologia (2011) 1.63
Oral androgens in the treatment of hypogonadal impotent men. J Urol (1994) 1.61
Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med (1986) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant (1997) 1.59
Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol (2001) 1.57
Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man. J Clin Pathol (1987) 1.56
Identification of the pace-maker current in frog atrium. J Physiol (1976) 1.56
Immune-mediated reactions to althesin (alphaxalone). Br J Anaesth (1976) 1.56
Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant (1991) 1.56
Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant (1992) 1.53
A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia (2010) 1.53
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Do facial averageness and symmetry signal health? Evol Hum Behav (2001) 1.52
Functional health status levels of primary care patients. JAMA (1983) 1.52
Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes (1983) 1.51
Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant (1997) 1.50
The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas. J Pathol (1989) 1.50
Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet (1988) 1.48
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
Seizures related to blood transfusion and erythropoietin treatment in patients undergoing dialysis. BMJ (1989) 1.48
The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill (2010) 1.46
Randomized clinical trial of fluid and salt restriction compared with a controlled liberal regimen in elective gastrointestinal surgery. Br J Surg (2013) 1.46
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits. Cardiovasc Res (1975) 1.44
Morphometric changes in rabbit ventricular myocardium produced by long-term beta-adrenoceptor blockade. Lancet (1977) 1.43
Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis (1993) 1.42
The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology. Br J Cancer (1989) 1.42
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet (1991) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J (Clin Res Ed) (1987) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ (1989) 1.38
Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia (2005) 1.38
Attractiveness of facial averageness and symmetry in non-western cultures: in search of biologically based standards of beauty. Perception (2001) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis (1978) 1.33
Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis. Br Med J (Clin Res Ed) (1983) 1.33
Molecular characterization of the alpha-glucosidase gene (malA) from the hyperthermophilic archaeon Sulfolobus solfataricus. J Bacteriol (1998) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells. J Pathol (1985) 1.31
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med (1979) 1.28
Spectrum of spontaneous frameshift mutations. Sequences of bacteriophage T4 rII gene frameshifts. J Mol Biol (1986) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci (1999) 1.27
Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett (2000) 1.25
Late referral for maintenance dialysis. Br Med J (Clin Res Ed) (1984) 1.25
Granular cell tumours revisited. An immunohistological and ultrastructural study. Histopathology (1988) 1.24
Inhibition of Neisseria gonorrhoeae by normal human saliva. Br J Vener Dis (1979) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Human lung tumours: a correlation of antigenic profile with histological type. Histopathology (1985) 1.22
Effect of decalcification agents on immunoreactivity of cellular antigens. J Clin Pathol (1987) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Endothelin: an important factor in acute renal failure? Lancet (1988) 1.19
An agent possibly associated with swine dysentery. Vet Rec (1970) 1.19
Osteoclasts contain macrophage and megakaryocyte antigens. J Pathol (1986) 1.19
The role of muscles in joint adaptation and degeneration. Langenbecks Arch Surg (2003) 1.19
Giant cell myocarditis: evidence for the macrophage origin of the giant cells. J Clin Pathol (1985) 1.19
Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia (1993) 1.18
Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol (1993) 1.18
Clinical experience with captopril in the treatment of severe drug-resistant hypertension. Am J Cardiol (1982) 1.17
Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut (1992) 1.16
Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia. Nature (1977) 1.16
Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut (1988) 1.15
Oxygen delivery from red cells. Biophys J (1985) 1.15
Estimating European admixture in African Americans by using microsatellites and a microsatellite haplotype (CD4/Alu). Hum Genet (1999) 1.14